Options meeting satisfice criteria (coagulation testing in trauma, blood gas testing in COPD, NT-proBNP in heart failure and sepsis, C-reactive protein in sepsis, Beta-HCG in pregnancy, biomarkers of traumatic brain injury) were automatically excluded from entering the platform trial because they met the satisfice criteria. The gene discussed is NPPB; the disease is heart failure.